Marzec A - Search Results

1

Acceptance of Illness and Compliance with Therapeutic Recommendations in Patients with Hypertension.

Pluta A, Sulikowska B, Manitius J, Posieczek Z, Marzec A, Morisky DE. Pluta A, et al. Among authors: marzec a. Int J Environ Res Public Health. 2020 Sep 17;17(18):6789. doi: 10.3390/ijerph17186789. Int J Environ Res Public Health. 2020. PMID: 32957678 Free PMC article.

2

Main Aspects of Preparing Diabetic Patients in Poland for Self-Care.

Pluta A, Marzec A, Kobus E, Sulikowska B. Pluta A, et al. Among authors: marzec a. Int J Environ Res Public Health. 2022 Sep 9;19(18):11365. doi: 10.3390/ijerph191811365. Int J Environ Res Public Health. 2022. PMID: 36141634 Free PMC article.

3

The determinants of coping with pain in chronically ill geriatric patients - the role of a sense of coherence.

Andruszkiewicz A, Basińska MA, Felsmann M, Banaszkiewicz M, Marzec A, Kędziora-Kornatowska K. Andruszkiewicz A, et al. Among authors: marzec a. Clin Interv Aging. 2017 Feb 9;12:315-323. doi: 10.2147/CIA.S118136. eCollection 2017. Clin Interv Aging. 2017. PMID: 28223789 Free PMC article.

4

Comparative bioavailability of verapamil from rapidly absorbed and slow release preparations.

Jankowski A, Marzec A, Lamparczyk H. Jankowski A, et al. Among authors: marzec a. J Pharm Biomed Anal. 1992 Oct-Dec;10(10-12):1101-3. doi: 10.1016/0731-7085(91)80129-w. J Pharm Biomed Anal. 1992. PMID: 1298370 No abstract available.

5

Fluorescence enhancement of two terpenes commonly present in essential oils.

Ochocka RJ, Marzec A, Lamparczyk H. Ochocka RJ, et al. Among authors: marzec a. J Pharm Biomed Anal. 1992 Oct-Dec;10(10-12):809-12. doi: 10.1016/0731-7085(91)80085-n. J Pharm Biomed Anal. 1992. PMID: 1298387

6

[Clinical pharmacokinetics of the nifedipine preparations Adalat, Corinfar and Cordafen-Polfa].

Marzec A, Bogdan M, Jankowski A, Nartowicz E, Wichliński LM. Marzec A, et al. Kardiol Pol. 1987;30 Suppl:65-71. Kardiol Pol. 1987. PMID: 3454387 Polish. No abstract available.

7

[False results of measuring digoxin levels in patients with renal failure. Comparison of the RIA--FPIA methods].

Jankowski A, Karwowski J, Marzec A, Kretowicz W, Nartowicz E. Jankowski A, et al. Among authors: marzec a. Kardiol Pol. 1990 Feb;33(2):116-21. Kardiol Pol. 1990. PMID: 2277482 Polish.

8

[Interaction between digoxin and nifedipine in the pharmacokinetic phase].

Jankowski A, Karwowski J, Marzec A, Nartowicz E. Jankowski A, et al. Among authors: marzec a. Kardiol Pol. 1987;30 Suppl:72-5. Kardiol Pol. 1987. PMID: 3331401 Clinical Trial. Polish. No abstract available.

9

[Digoxin level as a limited drug toxicity indicator in the assessment of post-digitalis arrhythmia].

Sinkiewicz W, Marzec A, Jankowski A, Hoffmann A. Sinkiewicz W, et al. Among authors: marzec a. Wiad Lek. 1994 Nov-Dec;47(21-24):808-12. Wiad Lek. 1994. PMID: 8999691 Polish.

10

[Verification of therapeutic levels of procainamide and N-acetyl- procainamide in ventricular arrhythmia].

Sinkiewicz W, Marzec A, Jankowski A, Hoffmann A, Makuch K, Romański B. Sinkiewicz W, et al. Among authors: marzec a. Pol Tyg Lek. 1990 Jun 4-11;45(23-24):458-60. Pol Tyg Lek. 1990. PMID: 1703654 Clinical Trial. Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters